BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang L, Zhang D, Han W, Guo C. High-mobility group box-1 inhibition stabilizes intestinal permeability through tight junctions in experimental acute necrotizing pancreatitis. Inflamm Res 2019;68:677-89. [DOI: 10.1007/s00011-019-01251-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Liu Y, Li Y, Xia Y, Liu K, Ren L, Ji Y. The Dysbiosis of Gut Microbiota Caused by Low-Dose Cadmium Aggravate the Injury of Mice Liver through Increasing Intestinal Permeability. Microorganisms 2020;8:E211. [PMID: 32033263 DOI: 10.3390/microorganisms8020211] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
2 Foerster EG, Mukherjee T, Cabral-Fernandes L, Rocha JDB, Girardin SE, Philpott DJ. How autophagy controls the intestinal epithelial barrier. Autophagy 2021;:1-18. [PMID: 33906557 DOI: 10.1080/15548627.2021.1909406] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Zhao T, Zhu Y, Yao L, Liu L, Li N. IGF-1 alleviates CCL4-induced hepatic cirrhosis and dysfunction of intestinal barrier through inhibition TLR4/NF-κB signaling mediated by down-regulation HMGB1. Ann Hepatol 2021;:100560. [PMID: 34653689 DOI: 10.1016/j.aohep.2021.100560] [Reference Citation Analysis]
4 Ye C, Zhang Y, Ding X, Guo C. High-Mobility Group Box-1 Is Critical in the Pathogenesis of Mouse Experimental Necrotizing Enterocolitis. J Interferon Cytokine Res 2021;41:319-28. [PMID: 34543127 DOI: 10.1089/jir.2021.0056] [Reference Citation Analysis]
5 Gaskell H, Ge X, Desert R, Das S, Han H, Lantvit D, Guzman G, Nieto N. Ablation of Hmgb1 in Intestinal Epithelial Cells Causes Intestinal Lipid Accumulation and Reduces NASH in Mice. Hepatol Commun 2020;4:92-108. [PMID: 31909358 DOI: 10.1002/hep4.1448] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
6 Jiang X, Zheng YW, Bao S, Zhang H, Chen R, Yao Q, Kou L. Drug discovery and formulation development for acute pancreatitis. Drug Deliv 2020;27:1562-80. [PMID: 33118404 DOI: 10.1080/10717544.2020.1840665] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Ge P, Luo Y, Okoye CS, Chen H, Liu J, Zhang G, Xu C, Chen H. Intestinal barrier damage, systemic inflammatory response syndrome, and acute lung injury: A troublesome trio for acute pancreatitis. Biomed Pharmacother 2020;132:110770. [PMID: 33011613 DOI: 10.1016/j.biopha.2020.110770] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Liu Y, Cui X, Gao MQ, Xue M, Xu H, Chang Z, Jiang Y, Liang H. Aplysin Retards Pancreatic Necrosis and Inflammatory Responses in NOD Mice by Stabilizing Intestinal Barriers and Regulating Gut Microbial Composition. Mediators Inflamm 2020;2020:1280130. [PMID: 32801992 DOI: 10.1155/2020/1280130] [Reference Citation Analysis]